News

Additionally, Olsen, who is the company’s current chief operating officer, will continue to serve in that capacity for both divisions while the board of directors engages in a

IQ announced that it has successfully completed PER.C6 clone generation for the production of its two fully human monoclonal antibodies, or mAbs, against the anthrax lethal toxin components

Professor David Garrod of Manchester’s Faculty of Life Sciences said the research, which was recently shortlisted for the Northwest Regional Development Agency’s Bionow project of the year, takes

By combining molecular imaging techniques with human cancer cell culture and animal model approaches, the researchers were able to reveal the ability of the compounds to kill human

Researchers at L’Aquila University in Italy conducted a comparative analysis by supplementing 86 patients with severe chronic venous insufficiency (CVI) with Pycnogenol and Daflon, a combination of diosmin

The phase II trial will test different vaccine dosages and schedules in 400 healthy volunteers between the ages of 18 and 55. The clinical trial is underway and

The multi-centered, placebo-controlled, parallel group trial was undertaken to establish formal dose response data of Fentanyl Taifun, with primary efficacy endpoints being the time to significant pain relief

ATI-7505, indicated for the treatment of gastrointestinal disorders such as gastroesophageal reflux disease (GERD) and gastroparesis (delayed emptying of the stomach), is an oral, serotonin type 4 (5HT4)

Curis said that recent results from the study showed that the formulation did not downregulate the targeted pharmacodynamic marker in this tumor, suggesting that the drug candidate may